HOME >> BIOLOGY >> NEWS
LDL receptor reduces LDL production, removes cholesterol from blood

MADISON -- A cell membrane protein thought mainly to bind "bad" cholesterol and remove it from circulation also plays a major role in reducing the production of that cholesterol, according to a study published this February in the Journal of Clinical Investigation.

The University of Wisconsin-Madison study provides new insights into the nature of lipoprotein overproduction in people with familial hypercholesterolemia (FH), an inherited disease that affects one in 500 people. The research also explains how statins, a class of medications taken by several million Americans, work to lower blood cholesterol levels.

Low-density lipoprotein (LDL) carries cholesterol to other cells in the body that need it. People whose blood levels of LDL -- the "bad" cholesterol -- are too high have an increased risk of heart disease. Individuals with FH have extremely high levels of LDL and are at high risk for heart attacks at an early age.

"In the 1970s researchers discovered that the LDL receptor is responsible for removing most of the cholesterol from blood," according to Alan Attie, a biochemist in the UW-Madison College of Agricultural and Life Sciences. "They showed that a mutation in the gene that codes for the LDL receptor causes FH. Most people thought that the receptor's major function was to clear LDL from blood."

However, scientists later found that people with FH have high LDL levels not only because they clear it from their blood too slowly, but also because they produce too much, Attie says. "Ours is the first study that explains the paradox of why people with FH produce too much LDL," he says. "We showed that functional LDL receptors increase the degradation of apolipoprotein B inside liver cells."

Apolipoprotein B (apoB) is the major protein component of very low-density lipoprotein, which is made by liver cells and converted to LDL in the blood. The rate of apoB production in liver cells -- and thus LDL production -- is determined by how much a
'"/>

Contact: Alan Attie
attie@biochem.wisc.edu
608-262-1372
University of Wisconsin-Madison
4-Apr-2000


Page: 1 2 3

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
3. Two-pronged attack targeting EGF receptor hinders cancer cell growth
4. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
5. Dioxin-receptor network identified
6. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
7. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus
8. Activation of receptor ups development of precancerous intestinal polyps
9. Researchers find an association between alcohol dependence and the GABAA receptor gene GABRG3
10. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?
11. Estrogen receptor-a disruption and vasodilation in coronary arteries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... R&D, today announced that it has entered into a multi-year contract with ... to support their translational and clinical research strategy to discover and develop ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
Breaking Biology Technology:
Cached News: